AN2 Therapeutics, Inc. (ANTX) Operating cash flow 2021–2025
AN2 Therapeutics, Inc. (ANTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.8MFY2025 · since FY2021: -$20.5M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | +39.4% |
| FY2024 | -$49.3M | +7.6% |
| FY2023 | -$53.3M | -59.2% |
| FY2022 | -$33.5M | -63.4% |
| FY2021 | -$20.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice